LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS
|
|
- Joshua French
- 6 years ago
- Views:
Transcription
1 LUPUS 101 LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS SLE SUBSETS SUBACUTE CUTANEOUS LUPUS DRUG INDUCED LUPUS NEONATAL LUPUS LATE ONSET LUPUS ANTI-PHOSPHOLIPID SYNDROME AUTOIMMUNE DISEASE IMMUNOLOGY 101: SELF VS NON-SELF AUTOIMMUNE DISEASE: PROBLEMS WITH IMMUNOLOGY 101 END RESULT: OVERACTIVE IMMUNE SYSTEM INFLAMING THE BODY ORGAN SPECIFIC OR SYSTEMIC FACTORS: GENETIC, HORMONAL, ENVIRONMENTAL 1
2 SLE CLASSIFICATION CRITERIA MALAR RASH: FIXED ERYTHEMA, FLAT OR RAISED,SPARING THE NASOLABIAL FOLDS DISCOID RASH: RAISED PATCHES, ADHERENT KERATOTIC SCALING, FOLLICULAR PLUGGING, OLDER LESIONS MAY CAUSE SCARRING PHOTOSENSITIVITY: RASH FROM SUNLIGHT SLE CLASSIFICATION CRITERIA ORAL/NASOPHARYNGEAL ULCERS: USUALLY PAINLESS ARTHRITIS: NONEROSIVE, INFLAMMATORY, IN TWO OR MORE PERIPHERAL JOINTS SEROSITIS: PLEURITIS OR PERICARDITIS SLE CLASSIFICATION CRITERIA SLE CLASSIFICATION CRITERIA RENAL DISORDER: PERSISTANT PROTEINURIA OR CELLULAR CASTS NEUROLOGIC DISORDER: SEIZURES OR PSYCHOSIS HEMATOLOGIC DISORDER: HEMOLYTIC ANEMIA, LEUKOPENIA, LYMPHOPENIA, OR THROMBOCYTOPENIA IMMUNOLOGIC DISORDER: ANTI-DsDNA ANTIBODIES OR ANTI-Sm ANTIBODIES OR ANTI-PHOSPHOLIPID ANTIBODIES ANTINUCLEAR ANTIBODIES 2
3 DIAGNOSIS 4 YEAR DELAY CLINICAL FEATURES ON PRESENTATION ARTHRITIS OR ARTHRALGIAS: 75% SKIN INVOLVEMENT: 53% RENAL: 38% CONSTITUTIONAL: 53% NEUROLOGIC: 24% RAYNAUDS: 33% ORGAN INVOLVEMENT IN SLE ARTHRITIS OR ARTHRALGIAS: 85% SKIN: 78% SEROSITIS: 40% RENAL: 74% CONSTITUTIONAL: 77% NEUROLOGIC: 54% RAYNAUDS: 60% 3
4 4
5 5
6 ORGAN SYSTEMS PREGNANCY CARDIAC: PERICARDITIS PULMONARY: PLEURISY, PNEUMONIA NEUROLOGIC: ANY SYMPTOMS RENAL: FIVE FORMS OF INFLAMMATION HIGH RISK POPULATION! INCREASED RISK OF DISEASE FLARE IF ACTIVE DISEASE AT CONCEPTION RISK OF ADVERSE FETAL OUTCOME DOUBLES SPECIFIC PROBLEMS: ANTIPHOSPHOLIPID SYNDROME NEONATAL LUPUS SYNDROME 6
7 LABORATORY ANA 90% DSDNA 40-60% SSA (RO) 30-45% SSB (LA) 10-15% Sm 20% RNP 20-30% C3,C4 SEDIMENTATION RATE ANTIPHOSPHOLIPID SYNDROME VENOUS THROMBOSIS ARTERIAL THROMBOSIS RECURRENT FETAL LOSS EARLY MI/CVA LIVEDO RETICULARIS TREATMENT 7
8 FATIGUE COMMON!!!!!!!!!!!!! WIDE DIFFERENTIAL DIAGNOSIS: DISEASE ITSELF DEPRESSION, FIBROMYALGIA SLEEP DIFFICULTIES MEDICATIONS: STEROIDS, ALCOHOL, ANTI-HYPERTENSIVES WEAKNESS DECONDITIONING RASHES CLASSIFY THE RASH! PHOTOSENSITIVITY: COVER UP! CLOTHES BLOCKERS LIFESTYLE STEROID CREAM INTRALESIONAL INJECTIONS PLAQUENIL DAPSONE, IMMUNOSUPPRESSIVES TREATMENT OF MILD SLE ARTHRITIS: NSAIDS, PLAQUENIL CONSTITUTIONAL: LIFESTYLE MODIFICATION, PLAQUENIL ALOPECIA: PLAQUENIL, INTRALESIONAL STEROIDS RAYNAUDS: CONTROL OF ENVIRONMENT, VASODILATORS, TREATMENT OF MODERATE-SEVERE SLE CORTICOSTEROIDS IMMUNOSUPPRESSIVES CYCLOPHOSPHAMIDE AZATHIOPRINE MYCOPHENOLATE MOFITIL 8
9 TREATMENT HYDROXYCHLOROQUINE SAFE SLOW ONSET OF ACTION GOOD FOR MILD DISEASE: SKIN, JOINTS, ALOPECIA, CONSTITUTIONAL SX. TOXICITIES: OCULAR, ALLERGIC RASHES, NAUSEA STEROIDS VERY EFFECTIVE: ANTI-INFLAMMATORY IMMUNOSUPPRESSIVE FAST ONSET OF ACTION LASTING EFFECT MULTIPLE PREPARATIONS STEROIDS: TOXICITIES WEIGHT GAIN OSTEOPOROSIS AVASCULAR NECROSIS DIABETES CATARACTS, GLAUCOMA PANCREATITIS INFECTIONS POOR WOUND HEALING SALT, WATER RETENTION PSYCHIATRIC SYMPTOMS IMMUNOSUPPRESSIVES CYCLOPHOSHAMIDE: CNS, RENAL DISEASE TOXICITIES: MALIGNANCIES, INFECTIONS, HEMATOLOGIC, CONSTITUTIONAL, GI, STERILITY MYCOPHENOLATE MOFITIL: CNS, RENAL, SEVERE SKIN TOXICITIES: GI, HEMATOLOGIC, INFECTIONS AZATHIOPRINE: CNS, RENAL, SEVERE SKIN TOXICITIES: GI, HEMATOLOGIC, INFECTIONS 9
10 BELIMUMAB SURVIVAL FIRST DRUG APPROVED IN 50 YEARS TO TREAT SLE MECHANISM OF ACTION: MONOCLONAL ANTIBODY INHIBITS BIOLOGICAL ACTIVITY OF B LYMPHOCYTE STIMULATOR (BLyS) 2 STUDIES (BLISS 52,76): DECREASED DISEASE ACTIVITY, NOT ORGAN-SPECIFIC IMPROVED PROGNOSIS EARLIER DIAGNOSIS BETTER KNOWLEDGE OF THE DISEASE IMROVED LABORATORY IMPROVED/MORE RATIONAL APPROACH TO RX: STEROIDS IMMUNOSUPPRESSIVES ANTI-HYPERTENSIVES 10
9/25/2013 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) 1 Other Types of Lupus Discoid Lupus Erythematosus Lupus Pernio --- Sarcoidosis Lupus Vulgaris --- Tuberculosis of the face Manifestations of SLE Fever Rashes Arthritis
More informationDefinition Chronic autoimmune disease The body s immune system starts attacking itself Can affect most organs and tissues in the body Brain, lungs, he
LIVING WITH SYSTEMIC LUPUS ERYTHEMATOSUS Stacy Kennedy, M.D.,M.B.A. Rowan Diagnostic Clinic Salisbury, N.C. May 11, 2013 Agenda What is lupus Who is affected Causes of lupus Symptoms and organ involvement
More informationONE of the following:
Medical Coverage Policy Belimumab (Benlysta) EFFECTIVE DATE: 01 01 2012 POLICY LAST UPDATED: 11 21 2017 OVERVIEW Belimumab (Benlysta ) is indicated for the treatment of adult patients with active, autoantibody-positive,
More informationUNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS
UNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS Stacy Kennedy, M.D.,M.B.A. October 20, 2012 Agenda What is lupus Who is affected Causes of lupus Symptoms and organ involvement Diagnosis Treatment Pregnancy
More informationBenlysta (belimumab) Prior Authorization Criteria Program Summary
Benlysta (belimumab) Prior Authorization Criteria Program Summary This prior authorization applies to Commercial, NetResults A series, NetResults F series and Health Insurance Marketplace formularies.
More informationHigh Impact Rheumatology
High Impact Rheumatology Systemic Lupus Erythematosus Bernard Rubin, DO MPH Case 1: History A 45-year-old woman presents with severe dyspnea and cough. She was in excellent health until 4 weeks ago when
More informationAutoimmune Disease. Autoimmunity. Epidemiology. ACR Criteria for Diagnosis. Signs and Symptoms. Autoreactivity: Reactivity to self antigens:
Autoimmunity Reactivity to self antigens: Autoreactivity: Autoimmune Disease T cells B cells Leading to tissue damage or dysfunction Occurring in the absence of ongoing infection Epidemiology SLE Pathogenesis
More informationAutoimmunity. Autoimmune Disease
Autoimmunity Reactivity to self antigens: T cells B cells Autoimmune Disease Autoreactivity: Leading to tissue damage or dysfunction Occurring in the absence of ongoing infection 1 SLE Pathogenesis Immune
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Belimumab Table of Contents Coverage Policy... 1 General Background... 2 Coding/Billing Information... 4 References... 4 Effective Date... 11/15/2017 Next
More informationLiving with Lupus: An Insider s Perspective
Living with Lupus: An Insider s Perspective Pamela Thorpe, MD, FACP Lupus Foundation of America, Inc. Philadelphia Tri-State Chapter Volunteer May 2014 My Own Story Is it Lupus Yet? The What What is this?
More informationMANAGING THE PATIENT WITH POSITIVE ANA
MANAGING THE PATIENT WITH POSITIVE ANA Rafael F. Rivas-Chacon, M.D. Disclosures Grant/Research support for: Pfizer Study JIA A3921104 Tofacitinib not related to this presentation 1 Positive Antinuclear
More informationSLE and the Antiphospholipid Syndrome
SLE and the Antiphospholipid Syndrome Susan Y. Ritter MD, PhD Associate Physician Division of Rheumatology, Immunology and Allergy Department of Medicine Brigham and Women s Hospital Instructor in Medicine
More informationSummary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z
Topic Page: Systemic Lupus Erythematosus Summary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z What Is It? Lupus is thought to develop when the immune system
More information.,Dr Ali Alkazzaz Babylon collage of medicine 2016
.,Dr Ali Alkazzaz Babylon collage of medicine 2016 Lupus history Lupus is the Latin word for wolf 1 st used medically in the 10 th century Described clinically in the 19 th century Butterfly rash in 1845
More informationConflict of Interest. Systemic Lupus Erythematosus and the Antiphospholipid Syndrome Bonnie L. Bermas, MD Brigham and Women s Hospital.
Systemic Lupus Erythematosus and the Antiphospholipid Syndrome Bonnie L. Bermas, MD Brigham and Women s Hospital Conflict of Interest Disclosures: None Overview Diagnostic Classification Criteria of SLE
More informationSystemic Lupus Erythematosus
Systemic Lupus Erythematosus Marc C. Hochberg, MD, MPH Professor of Medicine and Head, Division of Rheumatology University of Maryland School of Medicine CASE: HISTORY A 26-year-old woman is seen for migratory
More informationInsights into the DX of Pediatric SLE
Insights into the DX of Pediatric SLE Dr. John H. Yost Pediatric Rheumatology Children s Hospital at Dartmouth Assistant Professor of Medicine Geisel School of Medicine at Dartmouth john.h.yost@hitchcock.org
More informationLiving with Lupus. LFA - Georgia Gary E Myerson MD Arthritis and Rheumatology of GA
Living with Lupus LFA - Georgia Gary E Myerson MD Arthritis and Rheumatology of GA LUPUS A REALITY CHECK LUPUS A REALITY CHECK LUPUS A REALITY CHECK LUPUS A REALITY CHECK SLE 1.5 million Americans: some
More informationLupus. Fast facts. What is lupus? What causes lupus? Who gets lupus?
Lupus Systemic lupus erythematosus, referred to as SLE or lupus, is sometimes called the "great imitator." Why? Because of its wide range of symptoms, people often confuse lupus with other health problems.
More informationPS + MPs PS - MPs 37% 36% 64% 64%
Supplementary Figure 1. Amount and distribution of phosphatidylserine negative (PS - ) and phosphatidylserine positive (PS + ) MPs in 280 SLE patients and 280 controls. Circles are proportional to the
More informationTo live with lupus, we need to know about lupus.
To live with lupus, we need to know about lupus. Zineb Aouhab, MD Assistant Professor of Medicine Loyola University Medical Center Division of Rheumatology 1 Where did the word lupus come from? The word
More informationDevelopment of SLE among Possible SLE Patients Seen in Consultation: Long-Term Follow-Up. Disclosures. Background. Evidence-Based Medicine.
Development of SLE among Patients Seen in Consultation: Long-Term Follow-Up Abstract # 1699 May Al Daabil, MD Bonnie L. Bermas, MD Alexander Fine Hsun Tsao Patricia Ho Joseph F. Merola, MD Peter H. Schur,
More informationArthritis & Rheumatology Clinics of Kansas PATIENT EDUCATION SYSTEMIC LUPUS ERYTHEMATOSUS
Arthritis & Rheumatology Clinics of Kansas PATIENT EDUCATION SYSTEMIC LUPUS ERYTHEMATOSUS Introduction: There is perhaps no rheumatic disease that evokes so much fear and confusion among both patients
More informationRheumatology Primer: What Labs and When
Rheumatology Primer: What Labs and When Irina Konon, MD Department of Internal Medicine Division of Rheumatology Medical College of Wisconsin Disclosures None 1 Objective Discuss principles of laboratory
More informationUPDATES ON PEDIATRIC SLE
UPDATES ON PEDIATRIC SLE BY ANGELA MIGOWA, PEDIATRIC RHEUMATOLOGIST/SENIOR INSTRUCTOR AKUHN MBCHB-UON, MMED-AKUHN,PEDIATRIC RHEUMATOLOGY- MCGILL UNIVERSITY HEALTH CENTRE ROSA PARKS OBJECTIVES RECOGNIZE
More informationCSTAR CASE STUDIES: BLOCK F Type 3 Hypersensitivity Reaction
CSTAR CASE STUDIES: BLOCK F Type 3 Hypersensitivity Reaction Setting: ER Mr. Smith I ve just felt so weak for so long, and I ve lost so much weight, and now I m having trouble breathing it s affecting
More informationLUPUS (SLE) MEDICAL SOURCE STATEMENT
LUPUS (SLE) MEDICAL SOURCE STATEMENT From: Re: (Name of Patient) (Social Security No.) Please answer the following questions concerning your patient s impairments. Attach relevant treatment notes, radiologist
More informationSystemic Lupus Erythematosus among Jordanians: A Single Rheumatology Unit Experience
Systemic Lupus Erythematosus among Jordanians: A Single Rheumatology Unit Experience Ala M. AlHeresh MD* ABSTRACT Objectives: To study the characteristics of Systemic Lupus Erythematosus in Jordan and
More information10/6/08. Systemic Lupus Erythematosus. SLE Epidemiology: who is at risk? Margrit Wiesendanger Division of Rheumatology, CUMC.
Systemic Lupus Erythematosus SLE Epidemiology: who is at risk? One of the most common autoimmune diseases affecting women of all ages Predominantly women in child-bearing years (M:F ratio is 1:10) Incidence
More informationUndifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD
Undifferentiated Connective Tissue Disease and Overlap Syndromes Mark S. Box, MD Overlap Syndromes As many as 25% of patients with rheumatic diseases with systemic symptoms cannot be definitely diagnosed
More informationAsk the Expert: Photosensitivity in Cutaneous Lupus
Ask the Expert: Photosensitivity in Cutaneous Lupus Victoria P. Werth, MD Department of Dermatology & Medicine University of Pennsylvania ; Philadelphia VA Hospital Overview Definition Impact of photosensitivity
More informationLupus and Friends Perspectives on common syndromes and Primary care responses
Lupus and Friends Perspectives on common syndromes and Primary care responses Paul H Caldron DO, PhD, FACP, FACR, MBA Arizona Arthritis and Rheumatology Associates, PC University of Arizona College of
More informationSystemic Lupus Erythematosus
A Patient s Guide to Systemic Lupus Erythematosus 2 kidneys. These changes make it impossible for the kidneys to function normally. The inflammation of SLE can be seen in the lining, covering, and muscles
More informationCentral Nervous System (CNS) and Lupus: Learn from the Experts. Betty Diamond, M.D. Feinstein Institute for Medical Research
Central Nervous System (CNS) and Lupus: Learn from the Experts Betty Diamond, M.D. Feinstein Institute for Medical Research Stages in SLE Pathogenesis Crow MK, Arth Res & Tx. 2009 ACR Criteria for the
More informationCIBMTR Center Number: CIBMTR Recipient ID: RETIRED. Today s Date: Date of HSCT for which this form is being completed: &
Systemic Lupus Erythematosus Pre-HSCT Data Sequence Number: Date Received: Registry Use Only Today s Date: Date of HSCT for which this form is being completed: & HSCT type: o autologous o allogeneic, o
More informationPolicy. Section: Medicine Effective Date: January 15, 2015 Subsection: Pathology/Laboratory Original Policy Date: December 5, 2014 Subject:
Last Review Status/Date: December 2014 Page: 1 of 10 Summary Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease that can be difficult to diagnose because patients often present
More informationRheumatology 101 A Pediatrician s Guide
Rheumatology 101 A Pediatrician s Guide Pediatric Staff and Alumni Day 2016 Dawn M. Wahezi, Yonit Sterba, Tamar Rubinstein Disclosures None Pick a Group Group 1 A child with a limp Group 2 ANA To test
More informationSystemic Lupus Erythematosus (SLE) Epidemiology of SLE (United States)
1:10-2:25pm Closing the Loop on Lupus: Primary Care s Key Role in the Elusive Diagnosis and Management of Patients SPEAKER Richard Sadovsky, MD Richard Furie, MD Disclosures This session is supported by
More informationLiving with Lupus. Helping Your Patient With Systemic Lupus Erythematosus By Hussein M. Halaby, MBBS, ABIM, FRCPC; and John M. Esdaile, MD, MPH, FRCPC
Focus on CME at the University McGill University of British Columbia Living with Lupus Helping Your Patient With Systemic Lupus Erythematosus By Hussein M. Halaby, MBBS, ABIM, FRCPC; and John M. Esdaile,
More informationDr. Venkateswari. R. Dr. Janani Sankar s unit Kanchi Kamakoti CHILDS Trust Hospital
Dr. Venkateswari. R. Dr. Janani Sankar s unit Kanchi Kamakoti CHILDS Trust Hospital Acknowledgements: KKCTH Dr. Ramkumar Consultant Dermatologist Dr. Ramprakash Consultant Ophthalmologist Dr. Prasad Manne
More informationEvidence Based Treatment of SLE with Treatment Algorithm. Dr. Md. Mujibur Rahman Professor of Medicine Shaheed Suhrawardy Medical College
Evidence Based Treatment of SLE with Treatment Algorithm Dr. Md. Mujibur Rahman Professor of Medicine Shaheed Suhrawardy Medical College Natural Histoty Inflammatory multisystem disease Onset usually between
More informationAutoimmune diseases. SLIDE 3: Introduction to autoimmune diseases Chronic
SLIDE 3: Introduction to autoimmune diseases Chronic Autoimmune diseases Sometimes relapsing : and remitting. which means that they present as attacks Progressive damage Epitope spreading more and more
More informationSystemic Lupus Erythematosus (SLE) Learning Objectives. Presenter Disclosure Information
9:30 10:45 AM Closing the Loop on Lupus: Primary Care s Key Role in the Elusive Diagnosis and Management of Patients Presenter Disclosure Information The following relationships exist related to this presentation:
More informationIs it Autoimmune or NOT! Presented to AONP! October 2015!
Is it Autoimmune or NOT! Presented to AONP! October 2015! Four main jobs of immune system Detects Contains and eliminates Self regulates Protects Innate Immune System! Epithelial cells, phagocytic cells
More informationLupus as a risk factor for cardiovascular disease
Lupus as a risk factor for cardiovascular disease SØREN JACOBSEN Department Rheumatology, Rigshospitalet Søren Jacobsen Main sponsors: Gigtforeningen Novo Nordisk Fonden Rigshospitalet Disclaimer: Novo
More informationEssential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT
Essential Rheumatology Dr Ellen Bruce Consultant Rheumatologist CMFT Saving the best for last! Apparently people recall best the first and last thing they re told. Far too difficult to include everything.
More informationSystemic lupus erythematosus in a male patient
IOP Conference Series: Earth and Environmental Science PAPER OPEN ACCESS Systemic lupus erythematosus in a male patient To cite this article: H Sibarani and Z Zubir 2018 IOP Conf. Ser.: Earth Environ.
More informationCOMPLEX CUTANEOUS LUPUS CASES PEARLS AND PITFALLS
COMPLEX CUTANEOUS LUPUS CASES PEARLS AND PITFALLS Benjamin F. Chong, MD, MSCS February 17, 2018 CONFLICTS OF INTEREST D I S CLOSURE OF R E LATI ONSHIPS W I T H I NDUSTRY Benjamin Chong, MD, MSCS F059 Complex
More informationEarly diagnosis of systemic lupus erythematosus in primary care by family doctors
ISSN 2229-5518 2,302 Early diagnosis of systemic lupus erythematosus in primary care by family doctors Saad Ali Alalyani, Abdullah Saad Alalyani, Sultan Salem Algethami, Hamad Sulayyih Alosaimi, Abdullah
More informationSection: Medicine Effective Date: January 15, 2016 Subsection: Pathology/Laboratory Original Policy Date: December 5, 2014 Subject:
Last Review Status/Date: December 2015 Page: 1 of 11 Summary Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease that can be difficult to diagnose because patients often present
More informationSystemic Lupus Erythematosus. Margrit Wiesendanger Division of General Medicine, CUMC
Systemic Lupus Erythematosus Margrit Wiesendanger Division of General Medicine, CUMC October 13, 2009 SLE Epidemiology: who is at risk? One of the most common autoimmune diseases affecting women of all
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: belimumab_benlysta 6/2011 2/2018 2/2019 3/2018 Description of Procedure or Service Belimumab (Benlysta) is
More informationCommittee Approval Date: May 9, 2014 Next Review Date: May 2015
Medication Policy Manual Policy No: dru248 Topic: Benlysta, belimumab Date of Origin: May 13, 2011 Committee Approval Date: May 9, 2014 Next Review Date: May 2015 Effective Date: June 1, 2014 IMPORTANT
More informationSystemic lupus erythematosus in 50 year olds
Postgrad Med J (1992) 68, 440-444 The Fellowship of Postgraduate Medicine, 1992 Systemic lupus erythematosus in 50 year olds I. Domenech, 0. Aydintug, R. Cervera, M. Khamashta, A. Jedryka-Goral, J.L. Vianna
More informationResidual Functional Capacity Questionnaire SYSTEMIC LUPUS ERYTHEMATOSUS
Residual Functional Capacity Questionnaire SYSTEMIC LUPUS ERYTHEMATOSUS Patient: DOB: Physician completing this form: Please complete the following questions regarding this patient's impairments and attach
More informationSystemic examination
PROLONGED FEVER IN AN ADOLESCENT BOY Dr.Praveena Lionel, DNB PG, Dr.Kannan (HOD) Railway Hospital, Perambur History 11 yrs old adolescent boy was admitted with c/o Fever -1 wk Myalgia -1 wk Arthralgia
More informationPolicy. Background
Last Review Status/Date: December 2016 Page: 1 of 11 Summary Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease that can be difficult to diagnose because patients often present
More informationPediatric Rheumatology: A Case-based Approach to the Basics. Hilary M. Haftel, MD, MHPE University of Michigan Department of Pediatrics
Pediatric Rheumatology: A Case-based Approach to the Basics Hilary M. Haftel, MD, MHPE University of Michigan Department of Pediatrics Disclosures I have no relevant financial relationships with the manufacturer(s)
More informationPeter H. Schur Elena M. Massarotti. Editors. Lupus Erythematosus. Clinical Evaluation and Treatment
Lupus Erythematosus Peter H. Schur Elena M. Massarotti Editors Lupus Erythematosus Clinical Evaluation and Treatment Editors Peter H. Schur Division of Rheumatology, Immunology, Allergy Brigham and Women
More informationSystemic lupus erythematosus (SLE) ... PRESENTATIONS... Epidemiology of Systemic Lupus Erythematosus. Based on a presentation by Susan Manzi, MD, MPH
... PRESENTATIONS... Epidemiology of Systemic Lupus Erythematosus Based on a presentation by Susan Manzi, MD, MPH Presentation Summary Tracking the epidemiology of systemic lupus erythematosus is problematic
More informationSLE-key Case Studies
SLE-key Case Studies Ellen M. Field, M.D. Lehigh Valley Health Network, Bethlehem, PA Donald E. Thomas, Jr., M.D., FACP, FACR, RhMSUS, CCD Arthritis and Pain Assoc. of PG County, Greenbelt, MD Case Study
More informationSystemic Lupus Erythematosus Defining Lupus
Autoimmune Resource and Research Centre Information Sheet Systemic Lupus Erythematosus Defining Lupus Lupus is a disorder of the immune system known as an autoimmune disease. In autoimmune diseases, the
More informationLearning about Lupus. Learning About Lupus. Lupus Society of Illinois
Learning About Lupus Learning about Lupus Lupus Society of Illinois 525 W. Monroe Street, Suite 900 Chicago, Illinois 60661 Robert S. Katz, M.D. Professor of Medicine Rush University Medical Center Northwestern
More informationRheumatology E-learning. University of Szeged Department of Rheumatology and Immunology
Rheumatology E-learning University of Szeged Department of Rheumatology and Immunology Overview Prototype autoimmune disease The most common and variable systemic autoimmune connective disease Female:male:
More informationSystemic Lupus Erythematosus in Children and Adolescents Beth S. Gottlieb and Norman T. Ilowite. DOI: /pir
Systemic Lupus Erythematosus in Children and Adolescents Beth S. Gottlieb and Norman T. Ilowite Pediatr. Rev. 2006;27;323-330 DOI: 10.1542/pir.27-9-323 The online version of this article, along with updated
More informationAzathioprine toxicity criteria and severity descriptors for the listing of biological agents for rheumatoid arthritis on the PBS
Azathioprine toxicity criteria and severity descriptors for the listing of biological agents for rheumatoid arthritis on the PBS Only valid for adult patients Azathioprine must be at a dose of at least
More informationCutanous Manifestation of Lupus Erythematosus. Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university
Cutanous Manifestation of Lupus Erythematosus Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university A 50-year old lady, who is otherwise healthy, presented to the dermatology clinic with
More informationSerum Biomarker Panel Testing for Systemic Lupus Erythematosus
Serum Biomarker Panel Testing for Systemic Lupus Erythematosus Policy Number: 2.04.123 Last Review: 8/2017 Origination: 8/2015 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue
More information* Autoantibody positive (i.e. antinuclear antibody or ANA titre 1:80 or anti-double stranded (ds) DNA antibody 30 IU/mL)
Benlysta (belimumab) Policy Number: 5.02.509 Last Review: 05/2018 Origination: 06/2011 Next Review: 05/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for Benlysta
More informationSYSTEMIC LUPUS ERYTHEMATOSUS: CURRENT CONCEPTS AND CLINICAL PEARLS. Dr Sheila Vasoo Consultant Division of Rheumatology NUHS
SYSTEMIC LUPUS ERYTHEMATOSUS: CURRENT CONCEPTS AND CLINICAL PEARLS Dr Sheila Vasoo Consultant Division of Rheumatology NUHS Listen to the Patient Concepts Diagnosis Immunopathogenesis Clinical Pearls Disease
More informationRheumatology for the Nurse Practitioner. Mary Derlacki, FNP Eugene Rheumatology
Rheumatology for the Nurse Practitioner Mary Derlacki, FNP Eugene Rheumatology Financial Relationships Amgen Genentech AbbVie IS THIS LUPUS? S.T. is a 45 y/o woman with 9 months of joint pain, fatigue,
More informationMP Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases
Medical Policy MP 2.04.123 Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases BCBSA Ref. Policy: 2.04.123 Last Review: 06/27/2018 Effective Date: 06/27/2018
More informationControversies in Women s Health: Clinical Dilemmas in Arthritis
Controversies in Women s Health: Clinical Dilemmas in Arthritis Jonathan Graf, M.D. Assistant Professor of Medicine, UCSF Division of Rheumatology, SFGH December, 2008 Approximate Prevalence of Rheumatic
More informationDisclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None
Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies Sarah Goglin MD Assistant Professor of Medicine Division of Rheumatology Disclosures None 1 [footer
More informationDemystifying. Systemic Lupus Erythematosus: Signs and Symptoms for Early Recognition. Teaching Fellows in Lupus Project
Demystifying Systemic Lupus Erythematosus: Signs and Symptoms for Early Recognition Teaching Fellows in Lupus Project Introduction: Why are we here? Lupus can take 4-6 years and 3 providers before diagnosis*
More informationThe Diagnosis of Lupus
The Diagnosis of Lupus LUPUSUK 2017 This information booklet has been produced by LUPUS UK 2017 LUPUS UK LUPUS UK is the registered national charity for people with systemic lupus erythematosus (SLE) and
More informationMedia Guide: Lupus Facts
Media Guide: Lupus Facts Lupus is a chronic, autoimmune disease that can damage any part of the body (skin, joints, and/or organs inside the body). Signs and symptoms tend to last longer than six weeks
More informationAntiphospholipid Syndrome Handbook
Antiphospholipid Syndrome Handbook Maria Laura Bertolaccini, Oier Ateka-Barrutia, and Munther A. Khamashta Antiphospholipid Syndrome Handbook Maria Laura Bertolaccini, MD, PhD Lupus Research Unit The Rayne
More informationImmune tolerance, autoimmune diseases
Immune tolerance, autoimmune diseases Immune tolerance Central: negative selection during thymic education deletion of autoreactive B-lymphocytes in bone marrow Positive selection in the thymus Negative
More informationGender Differences in the Clinical and Serological Features of Systemic Lupus Erythematosus in Malaysian Patients
o ORIGINAL ARTICLE Gender Differences in the Clinical and Serological Features of Systemic Lupus Erythematosus in Malaysian Patients M R Azizah, MBBCh*, S S Ainol, MMed**, N C T Kong, MRCP***, Y Normaznah,
More informationSystemic Lupus Erythematosus
#34462 Systemic Lupus Erythematosus COURSE #34462 5 CONTACT HOURS Release Date: 11/01/17 Expiration Date: 10/31/20 Systemic Lupus Erythematosus HOW TO RECEIVE CREDIT Read the enclosed course. Complete
More informationLABORATORY STANDARDS IN THE DIAGNOSIS AND THERAPY MONITORING OF SYSTEMIC LUPUS ERYTHEMATOSUS
LABORATORY STANDARDS IN THE DIAGNOSIS AND THERAPY MONITORING OF SYSTEMIC LUPUS ERYTHEMATOSUS Prof. Sandor Sipka, M.D., Ph.D. 3rd Department of Medicine, Institute for Internal Medicine, Medical and Health
More information10/25/2018. Autoimmunity and how to treat it. Disclosure. Why do we get autoimmunity? James Verbsky MD/PhD Pediatric Rheumatology/Immunology
Autoimmunity and how to treat it James Verbsky MD/PhD Pediatric Rheumatology/Immunology Disclosure None I will mention drug names and some brand names but I have no financial interest or any other ties
More informationCutaneous manifestations and systemic correlation in patients with lupus erythematosus and its subsets: a study of 40 cases
International Journal of Research in Dermatology Mahajan R et al. Int J Res Dermatol. 2018 Nov;4(4):479-483 http://www.ijord.com Original Research Article DOI: http://dx.doi.org/10.18203/issn.2455-4529.intjresdermatol20183407
More informationLate onset systemic lupus erythematosus in southern Chinese. Citation Annals Of The Rheumatic Diseases, 1998, v. 57 n. 7, p.
Title Late onset systemic lupus erythematosus in southern Chinese Author(s) Ho, CTK; Mok, CC; Lau, CS; Wong, RWS Citation Annals Of The Rheumatic Diseases, 1998, v. 57 n. 7, p. 437-440 Issued Date 1998
More informationTest Name Results Units Bio. Ref. Interval
135091662 Age 45 Years Gender Male 29/8/2017 120000AM 29/8/2017 100215AM 29/8/2017 110825AM Ref By Final RHEUMATOID AUTOIMMUNE COMREHENSIVE ANEL ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF), SERUM ----- 20-60
More informationManifestations and Presentations of Collagen Vascular Diseases. Joseph LaConti, M.D., Ph.D. Center for Arthritis and Rheumatic Diseases Miami, FL
Manifestations and Presentations of Collagen Vascular Diseases Joseph LaConti, M.D., Ph.D. Center for Arthritis and Rheumatic Diseases Miami, FL June 29, 2018 Disclosures Joseph LaConti, M.D., Ph.D., has
More informationSerum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases
Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases Policy Number: 2.04.123 Last Review: 8/2018 Origination: 8/2015 Next Review: 8/2019 Policy Blue Cross
More informationLupus The Clinical Perspective
Lupus The Clinical Perspective Anca D. Askanase, M.D., M.P.H. Associate Professor of Medicine Director Lupus Center Columbia University Medical Center New York-Presbyterian Hospital Systemic Lupus Erythematosus
More informationInterstitial Lung Disease
Interstitial Lung Disease Interstitial lung disease (ILD) is a broad category of lung diseases that includes more than 130 disorders which are characterized by scarring (i.e. fibrosis ) and/or inflammation
More informationPAEDIATRIC VASCULITIS
PAEDIATRIC VASCULITIS Lawrence Owino Okong o, Mmed (UoN); Mphil. (UCT). Lecturer, Department of Paediatrics and Child Health, University of Nairobi. Paediatrician/ Rheumatologist. OUTLINE Introduction
More informationCases I have Learned From. Jeffrey P. Callen, MD Professor of Medicine (Dermatology) University of Louisville
Cases I have Learned From Jeffrey P. Callen, MD Professor of Medicine (Dermatology) University of Louisville Jeffrey P. Callen, MD Disclosure (previous 12 months) Consultant/Advisory board Auxilium Consultant
More informationNew Onset Arthritis. Clinical Dilemmas in Arthritis and Rheumatology. Physical Examination. Other Pertinent History
New Onset Arthritis Clinical Dilemmas in Arthritis and Rheumatology Primary Care Principles and Practice October 2008 Jonathan Graf, MD Assistant Professor of Medicine, UCSF Division of Rheumatology, SFGH
More informationBudsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital
Budsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital Outline What is ANA? How to detect ANA? Clinical application Common autoantibody in ANA diseases Outline What is ANA? How to detect ANA? Clinical
More informationNATIONAL LABORATORY HANDBOOK. Laboratory Testing for Antinuclear antibodies
NATIONAL LABORATORY HANDBOOK Laboratory Testing for Antinuclear antibodies Document reference number CSPD013/2018 Document developed by National Clinical Programme for Pathology Revision number Version
More informationCOPYRIGHT. Systemic Lupus Erythematosus. A General Internal Medicine Perspective. George Stojan, MD
Systemic Lupus Erythematosus A General Internal Medicine Perspective George Stojan, MD Disclosures None Case #1 24 year old African American female presents with 6 weeks of stiffness affecting her hands
More informationRHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center
RHEUMATOLOGY OVERVIEW Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center What is Rheumatology? Medical science devoted to the rheumatic diseases
More informationLiving With Lupus. October 15 TH, 2016 Georgia Lupus Empowerment Summit WAMBUI MACHUA, MD
Living With Lupus October 15 TH, 2016 Georgia Lupus Empowerment Summit WAMBUI MACHUA, MD LUPUS Latin for wolf 13th century physician Rogerius used the word to describe erosive fascial lesions reminiscent
More informationand rheumatism arthritis THE 1982 REVISED CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC LUPUS ERYTHEMATOSUS SPECIAL ARTICLE
arthritis and rheumatism * Official Journal of the American Rheumatism Association Section of the Arthritis Foundation SPECIAL ARTICLE THE 1982 REVISED CRITERIA F THE CLASSIFICATION OF SYSTEMIC LUPUS ERYTHEMATOSUS
More informationA cross-sectional hospital based study of clinical and. patients from central rural India
original article A cross-sectional hospital based study of clinical and patients from central rural India Sachin Ratanlal Agrawal, Iadarilang Tiewsoh, Atulsingh Rajput, Ajitprasad Jain Access this article
More information